3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Colorectal Neoplasms
86
Ovarian Neoplasms
33
Breast Neoplasms
29
Carcinoma, Non-Small-Cell Lung
28
Colonic Neoplasms
23
Rectal Neoplasms
21
Fallopian Tube Neoplasms
17
Neoplasms
16
Neoplasm Metastasis
13
Carcinoma, Hepatocellular
13
Glioblastoma
11
Lung Neoplasms
10
Brain Neoplasms
8
Carcinoma, Renal Cell
7
Uterine Cervical Neoplasms
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Intestinal Neoplasms
5
Gastrointestinal Neoplasms
5
Digestive System Neoplasms
5
Brenner Tumor
5
Recurrence
4
Peritoneal Neoplasms
4
Glioma
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma of Lung
4
Rectal Diseases
3
Non-Squamous Non-Small Cell Lung Cancer
3
Liver Neoplasms
3
Intestinal Diseases
3
Gastrointestinal Diseases
3
Interventions
Radiotherapy
8
Cisplatin
3
Carboplatin
3
sargramostim
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Donepezil
2
cevimeline
1
beta Carotene
1
alpha-Tocopherol
1
Zinc Sulfate
1
Vortioxetine
1
Vitamin E
1
Standard of Care
1
Sodium Chloride
1
Salts
1
Radiotherapy, Conformal
1
Radiosurgery
1
Oxygen
1
Oxaliplatin
1
Neck Dissection
1
Mometasone Furoate
1
Meditation
1
Hyperbaric Oxygenation
1
Glutamine
1
G(M1) Ganglioside
1
Filgrastim
1
Fibroblast Growth Factor 7
1
Etoposide
1
Erythropoietin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Radiation Injuries
×
Bevacizumab
×
Clear all
NCT06888817
2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3
Recruiting
408 enrolled